Celiac Disease Market Growth Expected to Reach US$ 1,362.1 Million by 2034
The Celiac Disease Market is expected to witness significant growth in the coming years, with the market reaching a value of US$ 1,362.1 Million by 2034, showing a growth rate (CAGR) of 9.85% during 2023-2034. Enzyme supplements like lactase and alpha-galactosidase are being widely used to improve digestion and reduce symptoms of bloating and gas, further fueling market growth. Key players in the industry are investing heavily in exploring microbial therapies like fecal microbiota transplantation (FMT) and probiotics to alter the gut microbiome and alleviate inflammation in the intestine, which is driving market expansion. The adoption of gluten-detoxification therapies and the increasing use of non-invasive methods for diagnosing celiac disease using saliva are expected to propel market growth in the forecast period.
Exploring Effective Treatments for I.B.S.
Explore effective treatments for I.B.S. with insights from experts like Dr. Brian Lacy and Dr. William Chey. Learn about dietary modifications, medications, and the latest research findings to manage symptoms and improve quality of life.
Breath Analysis for Gut Issues
Learn about the potential of breath analysis in diagnosing gut health issues like IBS and SIBO. Owlstone Medical’s OMED Health offers at-home breath test kits for just £250, providing a non-invasive and affordable option for diagnosis and monitoring of gut-related problems.
Over 100 Passengers and Crew on Cunard Cruise Ship Queen Victoria Affected by Gastrointestinal Illness
Reports from the US Centers for Disease Control and Prevention have revealed that over 100 passengers and crew members on the Cunard cruise ship Queen Victoria have been affected by gastrointestinal illness during a three-week leg of a 107-night cruise….